Development of Device Therapy for Ventricular Arrhythmias

Holley, Loraine K.

doi:10.1016/j.hlc.2007.02.104

Cited by 5 publications

(2 citation statements)

References 70 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…ATP was incorporated in these devices and low-energy shocks for terminating VTs, substantial programmability, and telemetry functionalities [ 27 ]. For quick charging time and delivering high-voltage shocks, devices initially used had cylindrical aluminium electrolytic capacitors and silver vanadium pentoxide batteries [ 28 ]. Nevertheless, due to the short service time and high maintenance of these batteries, lithium-silver vanadium manganese oxide batteries are currently being utilized, extending an ICD's service life [ 29 ].…”

Section: Reviewmentioning

confidence: 99%

Evolution of Pacemakers and Implantable Cardioverter Defibrillators (ICDs) in Cardiology

Sahu,

Acharya,

Totade

2023

Cureus

View full text Add to dashboard Cite

Pacemakers and implantable cardioverter defibrillators (ICDs) have revolutionized cardiology by providing life-saving interventions for patients with cardiac rhythm disturbances. Pacing the heart is an effective treatment for people suffering from bradycardia caused by sinus node dysfunction or atrioventricular (AV) block, and electronic pacing has saved countless lives since its introduction into clinical practice. AV synchronization is the typical cycle of atrial depolarization and contraction followed by ventricular depolarization and contraction. The continuation of this cycle leads to appropriate ventricular filling and cardiac output. By contrast, the failure of the cycle results in AV asynchrony, which may result in heart failure. Cardiac resynchronization treatment (CRT) involves using customized pacemakers with or without implantable cardioverter defibrillators and tries to resynchronize the failing heart by enhancing myocardial contraction without increasing energy consumption. This review delves into the extensive journey of pacemakers and ICDs in the field of cardiology. It highlights the transformative impact of these devices on patient care and quality of life, emphasizing technological advancements, clinical applications, and prospects. This comprehensive review aims to provide insights into the dynamic landscape of cardiac rhythm management.

show abstract

Section: Reviewmentioning

confidence: 99%

Evolution of Pacemakers and Implantable Cardioverter Defibrillators (ICDs) in Cardiology

Sahu,

Acharya,

Totade

2023

Cureus

View full text Add to dashboard Cite

show abstract

“…First-generation devices contained cylindrical aluminium electrolytic capacitors and silver vanadium pentoxide batteries for rapid charge time and the delivery of high-voltage shocks [21]. Nowadays, lithium-silver vanadium manganese oxide batteries are used, which resulted in an increase of the service life of an ICD.…”

Section: The Devicementioning

confidence: 99%

Improvements in 25 Years of Implantable Cardioverter Defibrillator Therapy

et al. 2010

View full text Add to dashboard Cite

In 1980, Dr. Michel Mirowski and his team inserted the first implantable cardioverter defibrillator (ICD) in a patient. Initially, ICD therapy was not widely accepted, and many physicians actually considered this therapy unethical. Large secondary and primary prevention trials, demonstrating a beneficial effect of ICD therapy in selected patients not only on arrhythmic death but also on all-cause mortality, stimulated a rapid growth in the number of implants and increased patient’s and physician’s acceptance. Improvements in size and weight, arrhythmia discrimination capabilities, battery technology, shock waveform and output, monitoring capabilities and defibrillator electrode technology eventually resulted in the current large number of yearly implants. Today, almost 40 years after the conception of the ICD and 25 years after the first human implant, ICD therapy is the treatment of choice for patients at risk for life-threatening arrhythmias either as secondary or primary prevention. Furthermore, with the more recent addition of resynchronisation therapy to standard ICD therapy, it became possible to treat selected patients with advanced symptoms of heart failure and to lower the risk of sudden death.

show abstract

Assessment, Significance and Mechanism of Ventricular Electrical Instability after Myocardial Infarction

Richards

Denniss

2007

Heart, Lung and Circulation

View full text Add to dashboard Cite

Development of Device Therapy for Ventricular Arrhythmias

Cited by 5 publications

References 70 publications

Evolution of Pacemakers and Implantable Cardioverter Defibrillators (ICDs) in Cardiology

Evolution of Pacemakers and Implantable Cardioverter Defibrillators (ICDs) in Cardiology

Improvements in 25 Years of Implantable Cardioverter Defibrillator Therapy

Assessment, Significance and Mechanism of Ventricular Electrical Instability after Myocardial Infarction

Contact Info

Product

Resources

About